Literature DB >> 13751463

Measles encephalitis. Evaluation of treatment with adrenocorticotropin and adrenal corticosteroids.

S KARELITZ, M EISENBERG.   

Abstract

Entities:  

Keywords:  ADRENAL CORTEX HORMONES/therapy; CORTICOTROPIN/therapy; ENCEPHALITIS/virology; MEASLES/complications

Mesh:

Substances:

Year:  1961        PMID: 13751463

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  9 in total

1.  Measles encephalitis. A clinical study of 25 cases.

Authors:  U Sharma; S Saxena; K Desai
Journal:  Indian J Pediatr       Date:  1975-04       Impact factor: 1.967

2.  THE CHILD WITH A POSITIVE MANTOUX TEST.

Authors:  R K CHANDRA
Journal:  Indian J Pediatr       Date:  1964-09       Impact factor: 1.967

3.  CORTICOSTEROID TREATMENT FOR ACUTE MENINGOENCEPHALITIS: A RETROSPECTIVE STUDY OF 346 CASES.

Authors:  J BOE; C O SOLBERG; T SAETER
Journal:  Br Med J       Date:  1965-04-24

4.  A clinical profile of measles in Marathwada. A study of 115 cases.

Authors:  R N Chawhan; S H Talib; V H Talib
Journal:  Indian J Pediatr       Date:  1976-06       Impact factor: 1.967

5.  Para-infectious and post-vaccinal encephalomyelitis.

Authors:  P B Croft
Journal:  Postgrad Med J       Date:  1969-06       Impact factor: 2.401

6.  Measles encephalitis.

Authors:  G P Katiyar; S P Agrawal
Journal:  Indian J Pediatr       Date:  1974-12       Impact factor: 1.967

Review 7.  The effects of therapeutic measures in diseases caused by viruses.

Authors:  R P Larke
Journal:  Can Med Assoc J       Date:  1966-11-05       Impact factor: 8.262

8.  Acute encephalopathy associated with measles.

Authors:  R Kumar; A Kumar; A Dubey; P K Misra
Journal:  Indian J Pediatr       Date:  1989 May-Jun       Impact factor: 1.967

9.  Viral infections of Toronto children during 1965: II. Measles encephalitis and other complications.

Authors:  D M McLean; J M Best; P A Smith; R P Larke; G A McNaughton
Journal:  Can Med Assoc J       Date:  1966-04-23       Impact factor: 8.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.